Colgate-Palmolive India names Manish Anandani CEO as Prabha Narasimhan exits

Prabha Narasimhan will step down as CEO at close of business on Sept. 27 to take an Asia-Pacific marketing role. Colgate-Palmolive India has appointed former Kenvue India and South Asia MD Manish Anandani as CEO for five years from Sept. 28, subject to approvals.

— Source published Fri, 21 Aug, 2026, 09:17 IST · First seen Fri, 21 Aug, 2026, 09:41 IST · Source NDTV Profit

What happened

Colgate-Palmolive (India) · Colgate-Palmolive India CEO Prabha Narasimhan will step down on Sept. 27 after promotion to an Asia-Pacific marketing role. The

Key facts

  • Shares fell as much as 1.2% to Rs 1,887.95
  • Stock declined nearly 7% over the last 10 trading sessions
  • Prabha Narasimhan steps down effective close of business Sept. 27
  • Manish Anandani appointed for a five-year term from Sept. 28
  • Anandani has 30 years of experience
  • He joined Colgate-Palmolive in 2005 and left in 2018

Why this matters

The CEO change may create an opening to reassess growth priorities, portfolio strategy and partnership opportunities once Anandani establishes his operating agenda.

What to watch

  • Market-share trends versus Hindustan Unilever, Dabur, Patanjali and other value or naturals-led competitors.
  • First quarterly commentary from Anandani on volume growth, pricing, ad spend and premiumization.
  • Senior executive departures, new commercial or marketing appointments, and changes in distributor strategy.
  • Launch cadence in therapeutic oral care, whitening, toothbrushes, mouthwash and digital-first formats.
  • Gross-margin movement from commodity costs and the balance between promotional spending and price increases.
  • Whether the company articulates a broader wellness or personal-care adjacency strategy within the first two quarters.
  • Announce or retain a senior India leadership team to signal operating continuity.
  • Conduct a portfolio and channel review focused on toothpaste share, rural distribution, premium formats and e-commerce.
  • Increase emphasis on clinically positioned oral-care propositions, sensitivity and gum-health platforms.
  • Settle investor concerns through guidance on advertising investment, pricing, margins and succession-transition plans.
  • Evaluate adjacent personal-health or wellness opportunities where Colgate's brand and Anandani's experience can transfer.